Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
2001
Growth Inhibition of Liver Cancer Cells by PPARγ Ligands
publication
Author Information
Author(s): Rumi M A K, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H, Okuyama T, Fukuda R, Nagasue N, Kinoshita Y
Primary Institution: Shimane Medical University
Hypothesis
The study investigates the effect of PPARγ ligands on human hepatocellular carcinoma cells.
Conclusion
PPARγ ligands significantly inhibit the growth of human hepatocellular carcinoma cells.
Supporting Evidence
- All tested liver cancer cell lines expressed active PPARγ.
- Thiazolidinedione ligands troglitazone and pioglitazone inhibited cell growth.
- The growth inhibition was linked to reduced DNA synthesis and cell cycle progression.
Takeaway
Certain drugs can help stop liver cancer cells from growing by affecting how they work.
Methodology
The study used various human liver cancer cell lines to test the effects of PPARγ ligands.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website